If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.06    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.01 (18.182%)
Market Cap: £3.43m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Option Purchase and Exercise

13 Mar 2017 10:30

RNS Number : 2649Z
Empyrean Energy PLC
13 March 2017
 

This announcement contains inside information

 

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

13 March 2017

Empyrean Energy PLC ('Empyrean' or 'the Company')

 

Option Purchase and Exercise

 

Empyrean confirms that it was notified that on 10 March 2017 that Apnea Holdings Pty Ltd ("Apnea"), a company which is wholly-owned by Tom Kelly, CEO of Empyrean, on that date purchased options (the "Options") in respect of 63,000,000 ordinary shares of 0.2p each in in the Company ("Ordinary Shares") from a third party not connected with the Company (the "Seller"). The terms of the Options are set out below and the total consideration payable by Apnea in respect of the purchase of the Options was AU$275,000 (equivalent to approximately £171,000).

 

Number of Options

Exercise Price

Expiry Date

18,000,000

0.2 pence

19 July 2017

15,000,000

2.1 pence

19 July 2017

15,000,000

4.1 pence

25 March 2018

15,000,000

2.1 pence

26 July 2019

 

Further to the announcement on 15 December 2016, the first tranche of Options detailed above reflects the agreement reached between the Company and the Seller that, if this tranche of Options were to be exercised prior to shareholder approval being granted for the necessary capitalisation from reserves to allow the exercise price to be amended to 0.1p, then this tranche of Options would have an exercise price of 0.2p and convert into a greater number of 18,000,000 Ordinary Shares.

 

Empyrean also announces that, on 10 March 2017, it received notice from Apnea that it intended to exercise its option in relation to 18,000,000 Ordinary Shares at an exercise price of 0.2 pence each. Accordingly, the Company has issued and allotted 18,000,000 Ordinary Shares (the "New Ordinary Shares"). Application will be made for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to take place on 17 March 2017. These New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

Following this exercise, Tom Kelly has a beneficial interest in 38,881,563 Ordinary Shares, representing 16.21% per cent. of the enlarged issued share capital of the Company.

 

Following the transaction, Empyrean's total issued share capital will comprise 239,833,853 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

**ENDS**

 

Empyrean Energy plc

Tom Kelly

Tel: +61 8 9481 0389

Cenkos Securities plc

Neil McDonald

Tel: +44 (0) 131 220 9771

Beth McKiernan

Tel: +44 (0) 131 220 9778

Nick Tulloch

Tel: +44 (0) 131 220 9772

St Brides Partners Ltd

Elisabeth Cowell

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

Tel: +44 (0) 20 7236 1177

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tom Kelly

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer of the Company

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Empyrean Energy plc

b)

LEI

-

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over ordinary shares of 0.2p each ("Ordinary Shares")

Identification code

GB00B09G2351

b)

Nature of the Transaction

Purchase of options in respect of 63,000,000 Ordinary Shares and subsequent exercise of options in respect of 18,000,000 Ordinary Shares at 0.2p per Ordinary Share.

c)

Price(s) and volume(s)

Price

Volume

AU$275,000 (aggregate) (equivalent to approximately £171,000)

Options in respect of 63,000,000 Ordinary Shares with an exercise price of 0.2p to 4.1p per Ordinary Share

 Price

Volume

0.2p

18,000,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

13 March 2017

f)

Place of the transaction

London Stock Exchange, AIM (LON:EME)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGMFGFRGNZM
Date   Source Headline
23rd Sep 20219:50 amRNSAGM Company Presentation
2nd Sep 20217:00 amRNSAward of Drilling Contract for Jade Prospect
27th Aug 20219:00 amRNSPosting of Annual Report and Notice of AGM
26th Aug 20213:12 pmRNSFinal Results
26th Jul 20211:41 pmRNSHolding(s) in Company
9th Jul 20219:05 amRNSSecond Price Monitoring Extn
9th Jul 20219:00 amRNSPrice Monitoring Extension
9th Jul 20218:05 amRNS£5.02 million Placement
12th May 20214:40 pmRNSSecond Price Monitoring Extn
12th May 20214:36 pmRNSPrice Monitoring Extension
12th May 20212:06 pmRNSSecond Price Monitoring Extn
12th May 20212:00 pmRNSPrice Monitoring Extension
5th May 20217:00 amRNSJade prospect well design and engineering project
29th Apr 20214:41 pmRNSSecond Price Monitoring Extn
29th Apr 20214:36 pmRNSPrice Monitoring Extension
23rd Apr 20217:00 amRNSJade Drilling - Well design & engineering Project
22nd Apr 20214:35 pmRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNSUS Tax Refund Received
12th Apr 20217:00 amRNSUpgraded Internal Geological Chance of Success
25th Mar 20217:00 amRNSSacramento Basin Assets
17th Mar 20214:40 pmRNSSecond Price Monitoring Extn
17th Mar 20214:35 pmRNSPrice Monitoring Extension
4th Mar 20217:04 amRNSUS Tax Refund
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSInterim Results
21st Dec 20207:00 amRNSMako Gas Project - Updated Plan of Development
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:35 pmRNSPrice Monitoring Extension
28th Oct 20207:14 amRNSBorba Drilling Program
2nd Oct 20207:59 amRNSAppointment of Joint Broker
22nd Sep 202011:06 amRNSResults of Annual General Meeting
22nd Sep 20209:45 amRNSAGM Company Presentation and Question & Answers
21st Sep 20207:00 amRNSDirector/PDMR Shareholding
15th Sep 20208:34 amRNSAward of Options
15th Sep 20208:32 amRNSUpdate re: Annual General Meeting
11th Sep 20207:15 amRNSEmpyrean completes £640,500 Placement
11th Sep 20207:00 amRNSEmpyrean completes £200,000 Placement
21st Aug 202010:11 amRNSFinal Results
3rd Jun 20207:00 amRNSExtension agreed for first phase at Block 29/11
26th May 20207:00 amRNSMako Resource Audit Confirms Significant Upgrade
22nd May 20207:00 amRNSDuyung PSC Update, Indonesia
21st May 20207:00 amRNSBlock 29/11, China - Seismic Inversion Project
12th May 20207:40 amRNSResult of Open Offer
29th Apr 20207:00 amRNSCompany Update
22nd Apr 20207:26 amRNSLaunch of Open Offer
17th Apr 202010:57 amRNSUpdate on Fundraising
14th Apr 20207:30 amRNSSubscription and Proposed Placing
14th Apr 20207:00 amRNSResource Upgrade of Mako Gas Field
25th Mar 20202:11 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.